Cífková R. 1 , Škodová Z. 1 , Lánská V. 2 , Poledne R. 3 , Adámková V. 1 ,:
Longitudinal Trends
of Total and HDL-cholesterol in a Representative Population Sample of the Czech Republic
|
501 |
Soška V.:
Pathophysiological Aspects of Hyperlipoproteinaemias
|
506 |
Zadák Z., Bláha V., Hyšpler R., Žďánský P.:
Nutritional Aspects of Hyperlipoproteinae-
mias
|
510 |
Špinar J. 1 , Špinarová L. 2 , Vítovec J. 1:
Lipids and Chronic Heart Failure
|
515 |
Štejfa M.:
Lipids and Acute Coronary Syndrome
|
520 |
Hofírek I., Krejčí V. 1:
Lipids and Atherosclerosis of the Peripheral Vessels
|
529 |
Vaverková H.:
Dyslipoproteinaemia and Diabetes Mellitus
|
532 |
Zahálková J., Vaverková H., Krištof V.:
Dyslipoproteinaemia and Chronic Renal Failure
|
539 |
Studeník P.:
Lipid Disorders in Liver Diseases
|
547 |
Kuman M.:
Lipid Disorders after Organ Transplantations
|
549 |
Bláha V., Solichová D., Zadák Z.:
Dyslipoproteinaemia in the Elderly
|
551 |
Češka R.:
Objectives of Treatment of Hyperlipoproteinaemia
|
555 |
Brázdová Z., Fiala J.:
Effect of Non-pharmacological Intervention on Reduction of
Plasma Cholesterol
|
559 |
Soška V.:
Pharmacotherapy of Hyperlipoproteinaemias
|
565 |
